Earnings Feed
Start Free
Blueprint Medicines Corp·4

Mar 6, 4:21 PM ET

Namouni Fouad 4

4 · Blueprint Medicines Corp · Filed Mar 6, 2024

Insider Transaction Report

Form 4
Period: 2024-03-01
Blueprint Medicines CorpBPMC
Namouni Fouad
PRESIDENT, R & D
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-01+30,000→ 30,000 total
    Exercise: $95.12Exp: 2034-03-01→ Common Stock (30,000 underlying)
  • Award

    Common Stock

    2024-03-01+15,000→ 77,080 total
Footnotes (2)
  • [F1]The reported transaction involved the Reporting Person's receipt of grant of 15,000 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan.
  • [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2024 and as to an additional 1/48th of the shares underlying the option each month thereafter.

Documents

2 files